Rockwell Medical (RMTI) Common Equity (2010 - 2026)

Rockwell Medical has reported Common Equity for 17 years, with the latest figure at $35.9 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity rose 13.75% year-over-year to $35.9 million; the trailing twelve-month figure through Mar 2026 stood at $35.9 million (up 13.75% YoY), and the FY2025 full-year result was $37.0 million, up 13.49% from the prior year.
• Common Equity for Q1 2026 stood at $35.9 million, down from $37.0 million in the prior quarter.
• The five-year high for Common Equity was $37.0 million in Q3 2025, with the low at -$4.8 million in Q1 2022.
• Historically, Common Equity has averaged $22.8 million across 5 years, with a median of $21.5 million in 2023.
• The largest YoY upside for Common Equity was 456.45% in 2022 against a maximum downside of 118.36% in 2022.
• Rockwell Medical's Common Equity stood at $14.1 million in 2022, then surged by 50.94% to $21.3 million in 2023, then jumped by 53.05% to $32.6 million in 2024, then rose by 13.49% to $37.0 million in 2025, then retreated by 3.04% to $35.9 million in 2026.
• The last three Common Equity figures came in at $35.9 million (Q1 2026), $37.0 million (Q4 2025), and $37.0 million (Q3 2025), per Business Quant data.